GlassScriptPhysician profile
Namit Rohant
NPI 1639516636
$25,478.14
in general payments reported to CMS, 2019-2025
35 companies · $4,852 in 2025
The $4,852 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,814 · 2020: $2,249 · 2021: $440 · 2022: $1,646 · 2023: $4,646 · 2024: $7,832 · 2025: $4,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,595 · Consulting Fee: $3,938 · Travel and Lodging: $3,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,594.82 |
| Consulting Fee | $3,937.50 |
| Travel and Lodging | $3,797.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,297.23 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Talisman |
| Biotronik INC. | $2,182.38 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,355.43 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $958.29 | 2022-2025 | Jardiance |
| Pfizer INC. | $630.89 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $535.43 | 2023-2025 | Wainua, Andexxa |
| E.R. Squibb & Sons, L.L.C. | $523.36 | 2020-2024 | Camzyos |
| Boston Scientific Corporation | $505.72 | 2019-2025 | Cds - Mct/Cem Monitoring |
| Endotronix, INC. | $453.14 | 2024-2025 | Cordella Pulomonary Artery Pressure Sensor |
| Novartis Pharmaceuticals Corporation | $444.29 | 2019-2024 | |
| Amgen INC. | $418.05 | 2024-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $336.71 | 2023-2025 | Onpattro, Amvuttra |
| Kestra Medical Technology Services, INC. | $220.93 | 2023-2025 | Assure Wcd |
| Abiomed | $215.85 | 2023-2025 | Impella |
| Lantheus Medical Imaging, INC. | $174.76 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $133.11 | 2023-2024 | Xarelto |
| Allergan, INC. | $125.00 | 2019 | |
| Portola Pharmaceuticals, LLC | $123.44 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.03 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $108.49 | 2021-2024 | Uptravi, Opsumit |
| Irhythm Technologies, INC. | $71.93 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Respicardia, INC. | $67.82 | 2023-2024 | Remede System |
| Cardiac Dimensions, INC. | $56.94 | 2022 | |
| Novo Nordisk INC | $48.03 | 2023 | Ozempic |
| Atricure, INC. | $42.57 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $32.53 | 2024 | Arcalyst |
| Biosense Webster, INC. | $25.51 | 2019 | |
| Cvrx, INC. | $24.50 | 2024 | Barostim Neo System |
| Livanova USA, INC. | $22.31 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.06 | 2023 | |
| Philips North America LLC | $16.00 | 2023 | |
| Scpharmaceuticals INC. | $15.82 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $14.59 | 2023 | Arcalyst |
| Itamar Medical INC | $10.60 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Namit Rohant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.